-
methodologies such as, chromatography, spectroscopy and mass spectrometry with expertise in one or more of these techniques. Qualifications Must-Have Ph.D. in Analytical Chemistry or related field, with 0+ years
-
methodologies such as, chromatography, spectroscopy and mass spectrometry with expertise in one or more of these techniques. Qualifications Must-Have Ph.D. in Analytical Chemistry or related field, with 0+ years
-
to manufacture API. CRD scientists engage in all facets of development from small-scale synthesis in support of medicinal chemistry programs, to the development of the commercial synthetic route. In collaboration
-
technology to manufacture active pharmaceutical ingredients (API). CRD scientists engage in all facets of development from small-scale synthesis in support of medicinal chemistry programs, to the development
-
impact of the group. Qualifications Ph.D. in Chemical Engineering, Organic Chemistry or Mechatronic Engineering related discipline (or within 6 months of completing a program) or an Msc with 3+ years
-
stability. This position will closely collaborate with colleagues across PharmSci as well as with partners in Medicinal Chemistry, Pharmacokinetics & Drug Metabolism, and Clinical Pharmacology. You will be
-
conjugates will be developed. As a Chemistry Senior Scientist in the ADC Innovation Unit, you will help design and synthesize the payloads, linkers and linker-payloads required to prepare ADCs. You may also
-
MS in Chemistry, Chemical Engineering or related field, 2-5 years experience working in formulations lab and performing quality testing procedures. Project management experience is preferred. Must have
-
chemistry strategies through the development and execution of innovative synthetic chemistry. With your deep knowledge of Chemistry, you will use your scientific judgment to adapt methods and techniques
-
an energetic, highly motivated, and creative Sr. Scientist with a strong background in protein chemistry and/or protein engineering to join Pfizer Oncology's antibody-drug conjugate (ADC) discovery research team